Skip to main content

Abstract

In the past 25 years, a large number of biologically active peptides has been identified in both brain and peripheral tissues. However, our understanding of their role in physiology and disease has been often undermined by the lack of potent and selective antagonists.

This review represents a summary of the work presented during the IUPHAR 94 in the symposium on “Peptide receptor antagonists”. The section on cholecystokinin antagonists was presented by L.L. Iverson (Merck Sharp and Dohme, Harlow, UK) and J.D. Gardner (St. Louis University, MO, USA). The section on tachykinin antagonists was presented by R.M. Snider (Pfizer, Groton, CT, USA and Burroughs Wellcome Company Research Triangle Park, NC, USA) and J.M. Lundberg (Karolinska Institute, Stockholm, Sweden). The section on neurotensin antagonists was presented by D. Gully (Sanofi Recherche, Toulouse, France) and P. Kitabgi (IPMC CNRS, Sophia-Antipolis, Valbonne, France).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chang RS, Lotti VJ, Monaghan J, Birnbaum J, Stapley EO, Goetz MA et al A potent non-peptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science 1985; 230: 177–179.

    Article  PubMed  CAS  Google Scholar 

  2. Patel S, Smith AJ, Chapman KL, Fletcher AE, Kemp JA, Marshall GR et al. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B gastrin receptor antagonist with high affinity in vitro and high potency in vivo, Mol. Pharmacol. 1994; 46: 943–948.

    PubMed  CAS  Google Scholar 

  3. Talkad VD, Fortune KP, Pollo DA, Shah GN, Wank SA, Gardner JD. Direct demonstration of three different states of the pancreatic cholecystokinin receptor. Proc. Natl. Acad. Sci. USA 1994; 91: 1868–1872.

    Article  PubMed  CAS  Google Scholar 

  4. Delay-Goyet P, Franco-Cereceda A, Golsalves SF, Clingan CA, Lowe III JA, Lundberg JM. CP 96345 antagonism of NK1 receptors and smoke-induced protein extravasation is unrelated to its cardiovascular effects. Eur. J. Pharmacol. 1992; 222: 213–218.

    Article  PubMed  CAS  Google Scholar 

  5. Delay-Goyet P, Satoh H, Lundberg JM. Differences in the potency of CP 96345 and RP 67580, two new non-peptide antagonists selective for NK1 receptors in inhibiting responses evoked by stimulation of sensory nerves. Regul. Pept. 1993; 46: 304–306.

    Article  PubMed  CAS  Google Scholar 

  6. Satoh H, Lou YP, Lundberg JM. Inhibitory effects of capsazepine and SR 48968 on citric acid-induced bronchoconstriction in guinea-pigs. Eur. J. Pharmacol. 1993; 236: 367–372.

    Article  PubMed  CAS  Google Scholar 

  7. Kitabgi P, Nemeroff CB, editors. The neurobiology of neurotensin. Ann. New York Acad. Sci. Vol. 668, 1992, pp. 1–374.

    Google Scholar 

  8. Gully D, Canton M, Boigegrain R, Jeanjean F, Molimard JC, Poncelet M et al. Biochemical and pharmacological profile of a potent and selective non-peptide antagonist of neurotensin receptor. Proc. Natl. Acad. Sci. USA 1993; 90: 65–69.

    Article  PubMed  CAS  Google Scholar 

  9. Dubuc I, Costentin J, Terranova JP, Barnouin MC, Soubrié P, Le Fur G et al. Br. J. Pharmacol. 1994; 112: 352–354.

    PubMed  CAS  Google Scholar 

  10. Kitabgi P. Effects of neurotensin on intestinal smooth muscle: application to the study of structure-activity relationships. Ann. N.Y. Acad. Sci. 1982; 400: 37–52.

    Article  PubMed  CAS  Google Scholar 

  11. Labbé-Jullié C, Deschaintres S, Gully D, Le Fur G, Kitabgi P. Effect of the non-peptide neurotensin antagonist, SR 48692, and two enantiomeric analogs, SR 48527 and SR 49711, on neurotensin binding and contractile responses in guinea-pig ileum and colon. J. Pharmacol, exp. Ther. 1994; 271: 267–276.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Birkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

Rostene, W., Le Fur, G. (1995). Peptide Receptor Antagonists. In: Cuello, A.C., Collier, B. (eds) Pharmacological Sciences: Perspectives for Research and Therapy in the Late 1990s. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7218-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-7218-8_4

  • Publisher Name: Birkhäuser Basel

  • Print ISBN: 978-3-0348-7220-1

  • Online ISBN: 978-3-0348-7218-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics